The MECOM V7 transcript variant was present at increased levels in cervical, colon, and ovarian cancer compared to the normal tissue control where, importantly, its level coincided with the expression of E2F1 and PRMT5 (fig. Here, E2F1 is linked to ovarian carcinoma.